1
项与 利妥昔单抗生物类似药(Mabscale) 相关的临床试验Randomized Double Blind Phase I Trial Comparing Pharmacokinetics, Pharmacodynamics, Immunogenicity and Safety of Rituximab (Mabscale LLC, Russia)+ Methotrexate+ Folic Acid and MabThera® Methotrexate+ Folic Acid in Adult Patients With Moderate or Severe Rheumatoid Arthritis With Insufficient Response to Treatment Tumor Necrosis Factor (TNF-α)
A randomised, double blind, parallel group, multicentre study to compare the pharmacokinetics, pharmacodynamics, immunogenicity and safety of Rituximab (Mabscale LLC, Russia) versus MabThera® in patients with rheumatoid arthritis.
100 项与 利妥昔单抗生物类似药(Mabscale) 相关的临床结果
100 项与 利妥昔单抗生物类似药(Mabscale) 相关的转化医学
100 项与 利妥昔单抗生物类似药(Mabscale) 相关的专利(医药)
100 项与 利妥昔单抗生物类似药(Mabscale) 相关的药物交易